Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Prehabilitation for Patients With Resectable Gastric Cancer: A Randomized Controlled Trial

NCT05714878 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT05714878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05714878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Prehabilitation for Patients With Resectable Gastric Cancer: A Randomized Controlled Trial
Lead sponsor
Chinese PLA General Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 22, 2023
Completion date
December 31, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasm